Polydopamine-Antibiotic Composite Coating for Antibiofilm Applications

Gillian A Kropp1, Hannah Q Karp2, Jayasimha Rao2,3,4,5

  • 1Department of Chemistry, Virginia Tech, Blacksburg, Virginia, USA.

Macromolecular Bioscience
|December 5, 2025
PubMed

Insights

A new polymer coating embedded with gentamicin significantly reduces biofilm formation on urinary catheters. This polydopamine-gentamicin (PD-Gent) coating shows promise in preventing catheter-associated infections.

Area of Science:

  • Biomaterials Science
  • Infectious Diseases
  • Polymer Chemistry

Background:

  • Urinary catheterization affects 15-25% of hospitalized patients.
  • Catheter-associated infections are often caused by biofilm-forming Gram-negative bacteria.
  • Current solutions for preventing these infections are limited.

Purpose of the Study:

  • To develop and evaluate a novel polymer-based antimicrobial coating for urinary catheters.
  • To assess the antibiofilm efficacy of a polydopamine-gentamicin (PD-Gent) coating against Pseudomonas aeruginosa.
  • To determine the coating's versatility across different substrates and antimicrobial agents.

Main Methods:

  • A polymer coating (polydopamine) was embedded with gentamicin (PD-Gent).
  • The antibiofilm efficacy of PD-Gent was tested against Pseudomonas aeruginosa (PAO1) on various substrates.
  • PD-Gent coated silicone Foley catheters were challenged with PAO1 in artificial urine under continuous flow.

Main Results:

  • The PD-Gent coating significantly reduced PAO1 biofilm formation compared to uncoated controls.
  • The coating demonstrated consistent antibiofilm activity on polystyrene, PVC, and silicone.
  • PD-Gent coated Foley catheters inhibited biofilm formation by three-fold under continuous flow conditions.

Conclusions:

  • The PD-Gent coating is a promising strategy for reducing catheter-associated infections.
  • The coating is versatile, adaptable to different substrates and antibiotics.
  • This technology has strong potential for clinical application in preventing biofilm-related complications.

Related Concept Videos

Biofilms01:29

Biofilms

Biofilms are complex communities of microorganisms encased in a self-produced extracellular polysaccharide matrix attached to surfaces. These microbial consortia can include single or multiple species, providing enhanced survival benefits by forming organized, multilayered structures.The formation of biofilms occurs through four key stages: attachment, colonization, development, and dispersal.During attachment, free-swimming planktonic cells adhere to a surface, often facilitated by...
1.0K
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention01:05

Bioavailability Enhancement: Drug Stability Enhancement and GI Retention

Body:Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
184
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
6.7K